Navigating Market Access With Magnolia: July 23, 2026 Webinar Sign Up

2026 Health Policy Update: Key Developments in Washington and the Outlook for 2027

Thursday, July 23, 2026 | 12:00 – 1:00 PM ET

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

2026 Health Policy Update: Key Developments in Washington and the Outlook for 2027

Live webinar: Thursday, July 23, 2026 | 12:00 PM ET

The U.S. healthcare policy environment continues to evolve at a significant pace, with consequential activity underway across drug pricing, patient access, coverage, and biopharmaceutical innovation. For life sciences manufacturers, understanding the legislative and regulatory developments shaping the market access landscape is critical to informing strategic planning.

During this live webinar, experts from Magnolia Market Access and Latham & Watkins will provide a comprehensive review of key healthcare policy developments in Washington in 2026, along with a forward-looking perspective on what stakeholders should anticipate heading into 2027.

Topics will include current drug pricing policy and negotiation frameworks, evolving formulary and coverage dynamics, legislative activity affecting patient access, and the implications of ongoing regulatory change for the innovation pipeline.

What You’ll Learn

Attendees will gain perspective on:

  • Key 2026 legislative and regulatory developments shaping the U.S. healthcare policy landscape
  • Current drug pricing policy activity, including negotiation frameworks and implications for manufacturers
  • How evolving formulary, coverage, and affordability dynamics may affect patient access
  • Policy considerations that could influence biopharmaceutical innovation and the future access environment
  • What market access, policy, legal, and commercial teams should be watching as they plan for 2027

Join us for a timely discussion on key 2026 healthcare policy developments in Washington and what they may mean for drug pricing, patient access, coverage, biopharmaceutical innovation, and strategic planning heading into 2027.

Speakers:

Amanda Forys
Managing Partner, Magnolia Market Access

Tracy Baroni Allmon

Tracy Baroni Allmon
Vice President, Market Access & Health Policy

Christopher H. Schott

Christopher H. Schott,
Partner, Latham & Watkins, LLP